Editor-in-Chief’s Commentary: Gene Penetrance, Therapeutic Targets, and Regulatory Science

被引：0

作者：

Stephen P. Spielberg

机构：

来源：

Therapeutic Innovation & Regulatory Science | 2013年 / 47卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：289 / 290

页数：1

相关论文

共 50 条

[21] BLOOM,FLOYD, FORMER EDITOR OF REGULATORY-PEPTIDES BECOMES EDITOR-IN-CHIEF OF SCIENCE
PHILLIPS, MI
HAKANSON, R
REGULATORY PEPTIDES, 1995, 57 (02) : R5 - R5
[22] Editor-in-Chief's Commentary: The Changing Landscape of Drug Companies
Spielberg, Stephen P.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014, 48 (04) : 412 - 412
[23] Editor-in-Chief’s Commentary: The Changing Landscape of Drug Companies
Stephen P. Spielberg
Therapeutic Innovation & Regulatory Science, 2014, 48 : 412 - 412
[24] Chemist named editor-in-chief of Science
Widener, Andrea
CHEMICAL & ENGINEERING NEWS, 2016, 94 (22) : 17 - 17
[25] Editor's Commentary: Regulatory Science and the Science of Safety
Turner, J. Rick
DRUG INFORMATION JOURNAL, 2011, 45 (03): : 221 - 227
[26] Editor-in-Chief's Commentary: SAGE Publishes the Drug Information Journal
Turner, J. Rick
DRUG INFORMATION JOURNAL, 2012, 46 (01): : 5 - 6
[27] Editor-in-Chief's Introduction
Floyd, Deborah L.
COMMUNITY COLLEGE JOURNAL OF RESEARCH AND PRACTICE, 2013, 37 (09) : 661 - 661
[28] Editor-in-Chief's Column
Kovalchuk, M., V
Belushkin, A., V
CRYSTALLOGRAPHY REPORTS, 2022, 67 (01) : 1 - 2
[29] Editor-in-Chief's response:
Chien, Andrew A.
Communications of the ACM, 2019, 62 (11)
[30] Editor-in-Chief's Perspective
Gittinger, John W., Jr.
SURVEY OF OPHTHALMOLOGY, 2011, 56 (04) : 371 - 373

← 1 2 3 4 5 →